At-Home Treatment of Patients with Acute Attacks of Hereditary Angioedema with the Bradykinin B2 Receptor-Antagonist Icatibant

被引：1

作者：

Farkas, H. ^{[1
]}

Csuka, D. ^{[1
]}

Zotter, Z. ^{[1
]}

Varga, L. ^{[1
]}

Boeroecz, Z. ^{[1
]}

Temesszentandrasi, G. ^{[1
]}

Karadi, I. ^{[1
]}

机构：

[1] Semmelweis Univ, Budapest, Hungary

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2011年 / 127卷 / 02期

关键词：

D O I：

10.1016/j.jaci.2010.12.926

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：AB233 / AB233

页数：1

共 50 条

[31] Treatment of hereditary angioedema due to C1 inhibitor deficiency with Icatibant, a selective bradykinin B2 receptor antagonist: a safety perspective
Bork, K.
ALLERGY, 2008, 63 : 47 - 47
[32] TREATMENT OF 340 HEREDITARY ANGIOEDEMA ATTACKS WITH ICATIBANT, A BRADYKININ B2 RECEPTOR ANTAGONIST, DURING THE OPEN-LABEL EXTENSION PHASE OF THE FAST-1 CLINICAL TRIAL
Riedl, M.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A113 - A113
[33] Icatibant, a Selective Bradykinin B2 Receptor Antagonist Used in Hereditary Angioedema Due to C1 Inhibitor Deficiency
Bork, K.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB165 - AB165
[34] First use of icatibant (selective bradykinin receptor antagonist) in hereditary angioedema patients in the UK
Karanam, S.
Demptser, J.
Longhurst, H.
Gompels, M.
CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (12): : 1943 - 1943
[35] Icatibant acetate -: Treatment of hereditary angioedema -: Agent for liver cirrhosis -: Antiasthmatic drug -: Treatment of osteoarthritis pain -: Bradykinin B2 antagonist
Sorbera, LA
Fernández-Forner, D
Bayés, M
DRUGS OF THE FUTURE, 2006, 31 (02) : 101 - 106
[36] Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant
Schmidt, Peter W.
Hirschl, Michael M.
Trautinger, Franz
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (05) : 913 - 914
[37] A case series about the treatment of hereditary angioedema due to C1 inhibitor deficiency with icatibant, a selective bradykinin B2 receptor antagonist
Bork, K.
ALLERGY, 2010, 65 : 455 - 455
[38] Clinical experience with Icatibant for treatment of acute attacks in patients with hereditary angioedema
Oliveira Rodrigues do Valle, S.
Tavares Franca, A.
Afra Pires Levy, S.
Malheiros, T.
Mello, Y.
Sarquis Serpa, F.
Sevciovic Grumach, A.
Albuquerque Campos, R.
ALLERGY, 2012, 67 : 359 - 359
[39] Treatment of idiopathic angio-edema with Icatibant, a bradykinin B2 receptor antagonist
Bork, K.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 177 - 177
[40] Safety Evaluation of Icatibant, a Selective Bradykinin B2 Receptor Antagonist Used in Hereditary Angioedema Due to C1 Inhibitor Deficiency
Staubach, P.
Bork, K.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S100 - S100

← 1 2 3 4 5 →